Sergio Crovella is responsible of several international research projects on autoimmune and autoinflammatory diseases as well as on the role of host OMICs in the context of infectious diseases. He authored 480 publications, https://pubmed.ncbi.nlm.nih.gov/?term=crovella+s&sort=date  with h index=41  https://www.scopus.com/authid/detail.uri?authorId=7005713079), and speaks English, French, Portuguese, Spanish and Italian.

Currently at QU he is working on in silico Engineered Antimicrobial Peptides (EAP) using bioinformatics tools and wet lab validation of the EAP antimicrobial activity. He is also studying on the role of EAP as novel tools to fight different types of cancer (i.e. breast, prostate and colon) developing in vitro models of the diseases. He is collaborating with international stakeholders (Bioactivia, K-Laser and Coram), on the antimicrobial and anti—inflammatory effects of Laser and LED light using in vitro models, including the ones of SARS-CoV2 infection. Finally he is working on the impact of air pollution on respiratory (i.e. asthma) and skin diseases (atopic dermatitis).